JP Morgan Chase
WST icon

JP Morgan Chase’s West Pharmaceutical WST Stock Holding History

JP Morgan Chase’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$65.5K – 7777
2024
Q4 		$65.5K Sell
200
-700
-78% -$220K ﹤0.01% 5912
2024
Q3 		$270K Hold
900
– – ﹤0.01% 5264
2024
Q2 		$296K Sell
900
-3,800
-81% -$1.34M ﹤0.01% 4946
2024
Q1 		$1.86M Hold
4,700
– – ﹤0.01% 3899
2023
Q4 		$1.65M Buy
+4,700
New +$1.66M ﹤0.01% 3976
2022
Q4 		– Sell
-600
Closed -$148K – 7049
2022
Q3 		$148K Buy
+600
New +$183K ﹤0.01% 5095

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase's WST Position: Q1 2026 in Review

JP Morgan Chase increased its West Pharmaceutical (WST) stake by 279% in Q1 2026, buying an estimated $191M and bringing the position to 1,043,417 shares worth $256M. The position accounts for 0.02% of the portfolio, ranked #602.

JP Morgan Chase first reported a position in WST in Q2 2013 and has held it in 52 quarters since. The position peaked at $398M in Q1 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • JP Morgan Chase held 1,043,417 shares of West Pharmaceutical worth $256M as of Q1 2026.
  • JP Morgan Chase bought 768,457 West Pharmaceutical shares in Q1 2026, an estimated $191M.
  • West Pharmaceutical made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #602 holding.
  • JP Morgan Chase first reported a position in West Pharmaceutical in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's West Pharmaceutical position peaked at $398M in Q1 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.